Eosinophilic pneumonias

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 60, Issue 7, 2005, Pages 841-857

  Cottin, V ^a   Cordier, Jean François ^a  

^a LOUIS PRADEL HOSPITAL   (France)

Author keywords

Allergic bronchopulmonary aspergillosis; Churg Strauss syndrome; Eosinophil; Pneumonia

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA INTERFERON; AMINOSALICYLIC ACID; CAPTOPRIL; CORTICOSTEROID; COTRIMOXAZOLE; DICLOFENAC; ETHAMBUTOL; FENBUFEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROXYUREA; IBUPROFEN; IMATINIB; IMMUNOSUPPRESSIVE AGENT; MEPOLIZUMAB; MINOCYCLINE; NAPROXEN; PENICILLIN DERIVATIVE; PHENYLBUTAZONE; PIROXICAM; PYRIMETHAMINE; SULFONAMIDE; SULINDAC; TOLFENAMIC ACID; TRYPTOPHAN;

ADULT RESPIRATORY DISTRESS SYNDROME; ALLERGIC REACTION; BRONCHOPULMONARY ASPERGILLOMA; CHURG STRAUSS SYNDROME; EOSINOPHILIA; HISTOPATHOLOGY; HUMAN; HYPEREOSINOPHILIC SYNDROME; IDIOPATHIC DISEASE; LOEFFLER PNEUMONIA; LUNG DISEASE; PARASITOSIS; PNEUMONIA; PRIORITY JOURNAL; REVIEW;

ADRENAL CORTEX HORMONES; CHURG-STRAUSS SYNDROME; EOSINOPHILS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PULMONARY EOSINOPHILIA;

EID: 20444504388     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2005.00812.x     Document Type: Review

References (181)

1. Cordier JF. Eosinophilic pneumonias. In: Schwarz MI, King TE Jr, editors. Interstitial lung disease, 4th edn. Hamilton, Ontario: B.C. Decker Inc., 2003:657-700.
2. Cordier JF, Cottin V. Eosinophilic lung diseases. In: Murray BW, Nadel JA, editors. Textbook of respiratory medicine, 4th edn. Philadelphia: Saunders, 2005.
3. Schleimer RP, Bochner BS. The effects of glucocorticoids on human eosinophils. J Allergy Clin Immunol 1994;94:1202-1213.
4. Rothenberg ME. Eosinophilia. N Engl J Med 1998;338:1592-1600.
5. Kroegel C, Virchow JC Jr, Luttmann W, Walker C, Warner JA. Pulmonary immune cells in health and disease: the eosinophil leukocyte (Part I). Eur Respir J 1994;7:519-543.
6. Kroegel C, Warner JA, Virchow JC Jr, Matthys H. Pulmonary immune cells in health and disease: the eosinophil leukocyte (Part II). Eur Respir J 1994;7:743-760.
7. Marone G. Human eosinophils. Biological and clinical aspects. Basel: Karger, 2000.
8. Lampinen M, Carlson M, Hakansson LD, Venge P. Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 2004;59:793-805.
9. Shi HZ, Xiao CQ, Li CQ, Mo XY, Yang QL, Leng J et al. Endobronchial eosinophils preferentially stimulate T helper cell type 2 responses. Allergy 2004;59:428-35.
10. Shi HZ, Humbles A, Gerard C, Jin Z, Weller PF. Lymph node trafficking and antigen presentation by endobronchial eosinophils. J Clin Invest 2000;105:945-953.
11. Yu C, Cantor AB, Yang H, Browne C, Wells RA, Fujiwara Y et al. Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo. J Exp Med 2002;195:1387-1395.
12. Lee JJ, Dimina D, Macias MP, Ochkur SI, McGarry MP, O'Neill KR et al. Defining a link with asthma in mice congenitally deficient in eosinophils. Science 2004;305:1773-1776.
13. Humbles AA, Lloyd CM, McMillan SJ, Friend DS, Xanthou G, McKenna EE et al. A critical role for eosinophils in allergic airways remodeling. Science 2004;305:1776-1779.
14. Bochner BS. Verdict in the case of therapies versus eosinophils: the jury is still out. J Allergy Clin Immunol 2004;113:3-9.
15. Sterk PJ, Hiemstra PS. Eosinophil progenitors in sputum: throwing out the baby with the bath water? Am J Respir Crit Care Med 2004;169:549-550.
16. Menzies-Gow A, Flood-Page P, Sehmi R, Burman J, Hamid Q, Robinson DS et al. Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics. J Allergy Clin Immunol 2003;111:714-719.
17. Lamkhioued B, Abdelilah SG, Hamid Q, Mansour N, Delespesse G, Renzi PM. The CCR3 receptor is involved in eosinophil differentiation and is upregulated by Th2 cytokines in CD34+ progenitor cells. J Immunol 2003;170:537-547.
18. Kay AB, Menzies-Gow A. Eosinophils and interleukin-5: the debate continues. Am J Respir Crit Care Med 2003;167:1586-1587.
19. Garrett JK, Jameson SC, Thomson B, Collins MH, Wagoner LE, Freese DK et al. Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol 2004;113:115-119.
20. Munitz A, Levi-Schaffer F. Eosinophils: 'new' roles for 'old' cells. Allergy 2004;59:268-275.
21. Carrington CB, Addington WW, Goff AM, Madoff IM, Marks A, Schwaber JR et al. Chronic eosinophilic pneumonia. N Engl J Med 1969;280:787-798.
22. Liebow AA, Carrington CB. The eosinophilic pneumonias. Medicine (Baltimore) 1969;48:251-285.
23. Jederlinic PJ, Sicilian L, Gaensler EA. Chronic eosinophilic pneumonia. A report of 19 cases and a review of the literature. Medicine (Baltimore) 1988;67:154-162.
24. Olopade CO, Crotty TB, Douglas WW, Colby TV, Sur S. Chronic eosinophilic pneumonia and idiopathic bronchiolitis obliterans organizing pneumonia: comparison of eosinophil number and degranulation by immunofluorescence staining for eosinophil-derived major basic protein. Mayo Clin Proc 1995;70:137-142.
25. Tazelaar HD, Linz LJ, Colby TV, Myers JL, Limper AH. Acute eosinophilic pneumonia: histopathologic findings in nine patients. Am J Respir Crit Care Med 1997;155:296-302.
26. Anonymous. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. The BAL Cooperative Group Steering Committee. Am Rev Respir Dis 1990;141:S169-S202.
27. Pope-Harman AL, Davis WB, Allen ED, Christoforidis AJ, Allen JN. Acute eosinophilic pneumonia. A summary of 15 cases and review of the literature. Medicine (Baltimore) 1996;75:334-342.
28. Marchand E, Etienne-Mastroianni B, Chanez P, Lauque D, Leclerq P, Cordier JF. Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other? The Groupe d'Etudes et de Recherche sur les Maladies 'Orphelines' Pulmonaires (GERM'O'P). Eur Respir J 2003;22:8-13.
29. Marchand E, Reynaud-Gaubert M, Lauque D, Durieu J, Tonnel AB, Cordier JF. Idiopathic chronic eosinophilic pneumonia. A clinical and follow-up study of 62 cases. The Groupe d'Etudes et de Recherche sur les Maladies Orphelines' Pulmonaires (GERM'O'P). Medicine (Baltimore) 1998;77:299-312.
30. Gaensler E, Carrington C. Peripheral opacities in chronic eosinophilic pneumonia: the photographic negative of pulmonary edema. AJR Am J Roentgenol 1977;128:1-13.
31. Ebara H, Ikezoe J, Johkoh T, Kohno N, Takeuchi N, Kozuka T et al. Chronic eosinophilic pneumonia: evolution of chest radiograms and CT features. J Comput Assist Tomogr 1994;18:737-744.
32. Arakawa H, Kurihara Y, Niimi H, Nakajima Y, Johkoh T, Nakamura H. Bronchiolitis obliterans with organizing pneumonia versus chronic eosinophilic pneumonia: high-resolution CT findings in 81 patients. AJR Am J Roentgenol 2001;116:1053-1058.
33. Cottin V, Deviller P, Tardy F, Cordier JF. Urinary eosinophil-derived neurotoxin/protein X: a simple method for assessing eosinophil degranulation in vivo. J Allergy Clin Immunol 1998;101:116-123.
34. Cordier JF. Eosinophilic pneumonias. In: Schwarz MI, King TE Jr, editors. Interstitial lung disease, 3rd edn. Hamilton, Ontario: B.C. Decker Inc., 1998:559-595.
35. Katoh S, Taniguchi H, Matsubara Y, Matsumoto N, Fukushima K, Kadota J et al. Overexpression of CD44 on alveolar eosinophils with high concentrations of soluble CD44 in bronchoalveolar lavage fluid in patients with eosinophilic pneumonia. Allergy 1999;54:1286-1292.
36. Beninati W, Derdak S, Dixon PF, Grider DJ, Strollo DC, Hensley RE et al. Pulmonary eosinophils express HLA-DR in chronic eosinophilic pneumonia. J Allergy Clin Immunol 1993;92:442-449.
37. Saita N, Yamanaka T, Kohrogi H, Ando M, Hirashima M. Apoptotic response of eosinophils in chronic eosinophilic pneumonia. Eur Respir J 2001;17:190-194.
38. Kurashima K, Mukaida N, Fujimura M, Yasui M, Shinagawa T, Matsuda T et al. A specific elevation of RANTES in bronchoalveolar lavage fluids of patients with chronic eosinophilic pneumonia. Lab Invest 1997;76:67-75.
39. Katoh S, Matsumoto N, Fukushima K, Mukae H, Kadota JI, Kohno S et al. Elevated chemokine levels in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia. J Allergy Clin Immunol 2000;106:730-736.
40. Miyazaki E, Nureki S, Fukami T, Shigenaga T, Ando M, Ito K et al. Elevated levels of thymus- and activation-regulated chemokine in bronchoalveolar lavage fluid from patients with eosinophilic pneumonia. Am J Respir Crit Care Med 2002;165:1125-1131.
41. Katoh S, Matsumoto N, Matsumoto K, Fukushima K, Matsukura S. Elevated interleukin-18 levels in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia. Allergy 2004;59:850-856.
42. Steinfeld S, Golstein M, De Vuyst P. Chronic eosinophilic pneumonia (CEP) as a presenting feature of Churg-Strauss syndrome (CSS). Eur Respir J 1994;7:2098.
43. Hueto-Perez-de-Heredia JJ, Dominguez-del-Valle FJ, Garcia E, Gomez ML, Gallego J. Chronic eosinophilic pneumonia as a presenting feature of Churg-Strauss syndrome. Eur Respir J 1994;7:1006-1008.
44. Weynants P, Riou R, Vergnon JM, Vincent M, Wiesendanger T, Cordier JF et al. Pneumopathies chroniques à éosinophiles. Etude de 16 cas. Rev Mal Respir 1985;2:63-68.
45. Durieu J, Wallaert B, Tonnel AB. Long term follow-up of pulmonary function in chronic eosinophilic pneumonia. Eur Respir J 1997;10:286-291.
46. Minakuchi M, Niimi A, Matsumoto H, Amitani R, Mishima M. Chronic eosinophilic pneumonia: treatment with inhaled corticosteroids. Respiration 2003;70:362-366.
47. Hayakawa H, Sato A, Toyoshima M, Imokawa S, Taniguchi M. A clinical study of idiopathic eosinophilic pneumonia. Chest 1994;105:1462-1466.
48. Allen JN, Pacht ER, Gadek JE, Davis WB. Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure. N Engl J Med 1989;321:569-574.
49. Cheon JE, Lee KS, Jung GS, Chung MH, Cho YD. Acute eosinophilic pneumonia: radiographic and CT findings in six patients. AJR Am J Roentgenol 1996;167:1195-1199.
50. King MA, Pope-Harman AL, Allen JN, Christoforidis GA, Christoforidis AJ. Acute eosinophilic pneumonia: radiologic and clinical features. Radiology 1997;203:715-719.
51. Philit F, Etienne-Mastroianni B, Parrot A, Guerin C, Robert D, Cordier JF. Idiopathic acute eosinophilic pneumonia: a study of 22 patients. The Groupe d'Etudes et de Recherche sur les Maladies 'Orphelines' Pulmonaires (GERM'O'P). Am J Respir Crit Care Med 2002;166:1235-1239.
52. Rom WN, Weiden M, Garcia R, Yie TA, Vathesatogkit P, Tse DB et al. Acute eosinophilic pneumonia in a New York City firefighter exposed to World Trade Center dust. Am J Respir Crit Care Med 2002;166:797-800.
53. Nakajima M, Manabe T, Niki Y, Matsushima T. Cigarette smoke-induced acute eosinophilic pneumonia. Radiology 1998;207:829-831.
54. Shintani H, Fujimura M, Yasui M, Ueda K, Kameda S, Noto M et al. Acute eosinophilic pneumonia caused by cigarette smoking. Intern Med 2000;39:66-68.
55. Shintani H, Fujimura M, Ishiura Y, Noto M. A case of cigarette smoking-induced acute eosinophilic pneumonia showing tolerance. Chest 2000;117:277-279.
56. Nakajima M, Manabe T, Niki Y, Matsushima T, Takashi S. A case of cigarette smoking-induced acute eosinophilic pneumonia showing tolerance. Chest 2000;118:1517-1518.
57. Kawayama T, Fujiki R, Honda J, Rikimaru T, Aizawa H. High concentration of (1 → 3)-beta-D-glucan in BAL fluid in patients with acute eosinophilic pneumonia. Chest 2003;123:1302-1307.
58. Johkoh T, Muller NL, Akira M, Ichikado K, Suga M, Ando M et al. Eosinophilic lung diseases: diagnostic accuracy of thin-section CT in 111 patients. Radiology 2000;216:773-780.
59. Nakahara Y, Hayashi S, Fukuno Y, Kawashima M, Yatsunami J. Increased interleukin-5 levels in bronchoalveolar lavage fluid is a major factor for eosinophil accumulation in acute eosinophilic pneumonia. Respiration 2001;68:389-395.
60. Ogawa H, Fujimura M, Matsuda T, Nakamura H, Kumabashiri I, Kitagawa S. Transient wheeze. Eosinophilic bronchobronchiolitis in acute eosinophilic pneumonia. Chest 1993;104:493-496.
61. Kawayama T, Fujiki R, Morimitsu Y, Rikimaru T, Aizawa H. Fatal idiopathic acute eosinophilic pneumonia with acute lung injury. Respirology 2002;7:373-375.
62. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 1951;27:277-301.
63. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-192.
64. Katzenstein AL. Diagnostic features and differential diagnosis of Churg-Strauss syndrome in the lung. A review. Am J Clin Pathol 2000;114:767-772.
65. Churg A. Recent advances in the diagnosis of Churg-Strauss syndrome. Mod Pathol 2001;14:1284-1293.
66. Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999;78:26-37.
67. Della Rossa A, Baldini C, Tavoni A, Tognetti A, Neglia D, Sambuceti G et al. Churg-Strauss syndrome: clinical and serological features of 19 patients from a single Italian centre. Rheumatology (Oxford) 2002;41:1286-1294.
68. Solans R, Bosch JA, Perez-Bocanegra C, Selva A, Huguet P, Alijotas J et al. Churg-Strauss syndrome: outcome and long-term follow-up of 32 patients. Rheumatology (Oxford) 2001;40:763-771.
69. Churg A, Brallas M, Cronin SR, Churg J. Formes frustes of Churg-Strauss syndrome. Chest 1995;108:320-323.
70. Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 1984;63:65-81.
71. Reid AJC, Harrison BDW, Watts RA, Watkin SW, McCann BG, Scott DGI. Churg-Strauss syndrome in a district hospital. Q J Med 1998;91:219-229.
72. Keogh KA, Specks U. Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists. Am J Med 2003;115:284-290.
73. Chumbley LC, Harrison EG Jr, DeRemee RA. Allergic granulomatosis and angiitis (Churg-Strauss syndrome). Report and analysis of 30 cases. Mayo Clin Proc 1977;52:477-484.
74. Degesys GE, Mintzer RA, Vrla RF. Allergic granulomatosis: Churg-Strauss syndrome. AJR Am J Roentgenol 1980;135:1281-1282.
75. Choi YH, Im JG, Han BK, Kim JH, Lee KY, Myoung NH. Thoracic manifestation of Churg-Strauss syndrome: radiologic and clinical findings. Chest 2000;117:117-124.
76. Worthy SA, Muller NL, Hansell DM, Flower CD. Churg-Strauss syndrome: the spectrum of pulmonary CT findings in 17 patients. AJR Am J Roentgenol 1998;170:297-300.
77. Wallaert B, Gosset P, Prin L, Bart F, Marquette CH, Tonnel AB. Broncho-alveolar lavage in allergic granulomatosis and angiitis. Eur Respir J 1993;6:413-417.
78. Cottin V, Tardy F, Gindre D, Vernet G, Deviller P, Cordier JF. Urinary eosinophil-derived neurotoxin in Churg-Strauss syndrome. J Allergy Clin Immunol 1995;96:261-264.
79. Tsukadaira A, Okubo Y, Kitano K, Horie S, Momose T, Takashi S et al. Eosinophil active cytokines and surface analysis of eosinophils in Churg-Strauss syndrome. Allergy Asthma Proc 1999;20:39-44.
80. Shiota Y, Matsumoto H, Kanehisa Y, Tanaka M, Kanazawa K, Hiyama J et al. Serum interleukin-5 levels in a case with allergic granulomatous angiitis. Intern Med 1997;36:709-711.
81. Schonermarck U, Csernok E, Trabandt A, Hansen H, Gross WL. Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitides. Clin Exp Rheumatol 2000;18:457-463.
82. Cottin V, Cordier JF. Churg-Strauss syndrome. Allergy 1999;54:535-551.
83. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33:1094-1100.
84. Yousem SA, Lombard CM. The eosinophilic variant of Wegener's granulomatosis. Hum Pathol 1988;19:682-688.
85. Lie JT. Limited forms of Churg-Strauss syndrome. Pathol Ann 1993;28:199-220.
86. Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 1996;75:17-28.
87. Abu-Shakra M, Smythe H, Lewtas J, Badley E, Weber D, Keystone E. Outcome of polyarteritis nodosa and Churg-Strauss syndrome. An analysis of twenty-five patients. Arthritis Rheum 1994;37:1798-1803.
88. Cohen P, Pagnoux C, Mahr A, Mouthon L, Le Guern V, Andre MH, et al. Treatment of Churg-Strauss syndrome (CSS) without poor prognosis factor at baseline with corticosteroids (CS) alone. Preliminary results of a prospective multicenter trial. Arthritis Rheum 2003;48:S209.
89. Langford CA. Treatment of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: where do we stand? Arthritis Rheum 2001;44:508-512.
90. Gayraud M, Guillevin L, le Toumelin P, Cohen P, Lhote F, Casassus P et al. Long-term follow-up of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum 2001;44:666-675.
91. Tatsis E, Schnabel A, Gross WL. Interferon-alpha treatment of four patients with the Churg-Strauss syndrome. Ann Intern Med 1998;129:370-374.
92. Guillevin L, Guittard T, Bletry O, Godeau P, Rosenthal P. Systemic necrotizing angiitis with asthma: causes and precipitating factors in 43 cases. Lung 1987;165:165-172.
93. Lilly CM, Churg A, Lazarovich M, Pauwels R, Hendeles L, Rosenwasser LJ, et al. Asthma therapies and Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 2002;109:S1-S19.
94. Chusid MJ, Dale DC, West BC, Wolff SM. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 1975;54:1-27.
95. Bain BJ. Eosinophilic leukaemias and the idiopathic hypereosinophilic syndrome. Br J Haematol 1996;95:2-9.
96. Brito-Babapulle F. Clonal eosinophilic disorders and the hypereosinophilic syndrome. Blood Rev 1997;11:129-145.
97. Oliver JW, Deol I, Morgan DL, Tonk VS. Chronic eosinophilic leukemia and hypereosinophilic syndromes. Proposal for classification, literature review, and report of a case with a unique chromosomal abnormality. Cancer Genet Cytogenet 1998;107:111-117.
98. Schoffski P, Ganser A, Pascheberg U, Busche G, Gaede B, Hertenstein B. Complete haematological and cytogenetic response to interferon alpha-2a of a myeloproliferative disorder with eosinophilia associated with a unique t(4;7) aberration. Ann Hematol 2000;79:95-98.
99. Chang HW, Leong KH, Koh DR, Lee SH. Clonality of isolated eosinophils in the hypereosinophilic syndrome. Blood 1999;93:1651-1657.
100. Bigoni R, Cuneo A, Roberti MG, Milani R, Bardi A, Cavazzini F et al. Cytogenetic and molecular cytogenetic characterization of 6 new cases of idiopathic hypereosinophilic syndrome. Haematologica 2000;85:486-491.
101. Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood 1994;83:2759-2779.
102. Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH. The idiopathic hypereosinophilic syndrome: clinical, pathophysiologic and therapeutic considerations. Ann Intern Med 1982;97:78-92.
103. Spry CJF, Davies J, Tai PC, Olsen EGJ, Oakley CM, Goodwin JF. Clinical features of fifteen patients with the hypereosinophilic syndrome. Q J Med 1983;205:1-22.
104. Roberts WC, Ferrans VJ. Pathologic anatomy of the cardiomyopathies. Idiopathic dilated and hypertrophic types, infiltrative types, and endomyocardial disease with and without eosinophilia. Hum Pathol 1975;6:287-342.
105. Leiferman KM, Gleich GJ. Hypereosinophilic syndrome: case presentation and update. J Allergy Clin Immunol 2004;113:50-58.
106. Assa'ad AH, Spicer RL, Nelson DP, Zimmermann N, Rothenberg ME. Hypereosinophilic syndromes. Chem Immunol 2000;76:208-229.
107. Ommen SR, Seward JB, Tajik AJ. Clinical and echocardiographic features of hypereosinophilic syndromes. Am J Cardiol 2001;86:110-113.
108. Corradi D, Vaglio A, Maestri R, Legname V, Leonardi G, Bartoloni G et al. Eosinophilic myocarditis in a patient with idiopathic hypereosinophilic syndrome: insights into mechanisms of myocardial cell death. Human Pathol 2004;35:1160-1163.
109. Kang EY, Shim JJ, Kim JS, Kim KI. Pulmonary involvement of idiopathic hypereosinophilic syndrome: CT findings in five patients. J Comput Assist Tom 1997;21:612-615.
110. Cordier JF, Faure M, Hermier C, Brune J. Pleural effusions in an overlap syndrome of idiopathic hypereosinophilic syndrome and erythema elevatum diutinum. Eur Respir J 1990;3:115-118.
111. Simon HU, Plotz SG, Dummer R, Blaser K. Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med 1999;341:1112-1120.
112. Roufosse F, Schandene L, Sibille C, Willard-Gallo K, Kennes B, Efira A et al. Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome. Br J Haematol 2000;109:540-548.
113. Cogan E, Schandené L, Crusiaux A, Cochaux P, Velu T, Goldman M. Clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med 1994;330:535-538.
114. Roufosse F, Cogan E, Goldman M. The hypereosinophilic syndrome revisited. Annu Rev Med 2003;54:169-184.
115. Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001;107:535-541.
116. Leiferman KM, O'Duffy JD, Perry HO, Greipp PR, Giuliani ER, Gleich GJ. Recurrent incapacitating mucosal ulcerations. A prodrome of the hypereosinophilic syndrome. JAMA 1982;247:1018-1020.
117. Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003;348:1201-1214.
118. Griffin JH, Leung J, Bruner RJ, Caligiuri MA, Briesewitz R. Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome. Proc Natl Acad Sci USA 2003;100:7830-7835.
119. Butterfield JH, Gleich G. Response of six patients with idiopathic hypereosinophilic syndrome to interferon alpha. J Allergy Clin Immunol 1994;94:1318-1326.
120. Ceretelli S, Capochiani E, Petrini M. Interferon-alpha in the idiopathic hypereosinophilic syndrome: consideration of five cases. Ann Hematol 1998;77:161-164.
121. Plotz SG, Simon HU, Darsow U, Simon D, Vassina E, Yousefi S et al. Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis. N Engl J Med 2003;349:2334-2339.
122. Koury MJ, Newman JH, Murray JJ. Reversal of hypereosinophilic syndrome and lymphomatoid papulosis with mepolizumab and imatinib. Am J Med 2003;115:587-589.
123. Chitkara RK, Sarinas PS. Dirofilaria, visceral larva migrans, and tropical pulmonary eosinophilia. Semin Respir Infect 1997;12:138-148.
124. Malavige GN. Chronic cough and tropical pulmonary eosinophilia. BMJ 2003;326:1036.
125. Rom WN, Vijayan VK, Cornelius MJ, Kumaraswami V, Prabhakar R, Ottesen EA et al. Persistent lower respiratory tract inflammation associated with interstitial lung disease in patients with tropical pulmonary eosinophilia following conventional treatment with diethylcarbamazine. Am Rev Respir Dis 1990;142:1088-1092.
126. Sarinas PS, Chitkara RK. Ascariasis and hookworm. Semin Respir Infect 1997;12:130-137.
127. Schantz PM, Glickman LT. Current concepts in parasitology. Toxocaral visceral larva migrans. N Engl J Med 1978;298:436-439.
128. Beshear JR, Hendley JO. Severe pulmonary involvement in visceral larva migrans. Am J Dis Child 1973;125:599-600.
129. Igra-Siegman Y, Kapila R, Sen P, Kaminski ZC, Louria DB. Syndrome of hyperinfection with strongyloides stercoralis. Rev Infect Dis 1981;3:397-407.
130. Tonnel AB. Allergic bronchopulmonary aspergillosis. Allergy 2005, in press.
131. Kauffman HF, Tomee JF, van der Werf TS, de Monchy JG, Koeter GK. Review of fungus-induced asthmatic reactions. Am J Respir Crit Care Med 1995;151:2109-2116.
132. Bosken C, Myers J, Greenberger P, Katzenstein AL. Pathologic features of allergic bronchopulmonary aspergillosis. Am J Surg Pathol 1988;12:216-222.
133. Panchal N, Bhagat R, Pant C, Shah A. Allergic bronchopulmonary aspergillosis: the spectrum of computed tomography appearances. Respir Med 1997;91:213-219.
134. Angus RM, Davies ML, Cowan MD, McSharry C, Thomson NC. Computed tomographic scanning of the lung in patients with allergic bronchopulmonary aspergillosis and in asthmatic patients with a positive skin test to Aspergillus fumigatus. Thorax 1994;49:586-589.
135. Wagner RW. Gene inhibition using antisense oligodeoxynucleotides. Nature 1994;372:333-335.
136. Mastella G, Rainisio M, Harms HK, Hodson ME, Koch C, Navarro J et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis. Eur Respir J2001;16:464-471.
137. Venarske DL, deShazo RD. Sinobronchial allergic mycosis: the SAM syndrome. Chest 2002;121:1670-1676.
138. Marchand E, Verellen-Dumoulin C, Mairesse M, Delaunois L, Brancaleone P, Rahier JF et al. Frequency of cystic fibrosis transmembrane conductance regulator gene mutations and 5T allele in patients with allergic bronchopulmonary aspergillosis. Chest 2001;119:762-767.
139. Ponikau JU, Sherris DA, Kern EB, Homburger HA, Frigas E, Gaffey TA et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999;74:877-884.
140. Leonard CT, Berry GJ, Ruoss SJ. Nasal-pulmonary relations in allergic fungal sinusitis and allergic bronchopulmonary aspergillosis. Clin Rev Allergy Immunol 2001;21:5-15.
141. Mintzer RA, Rogers LF, Kruglik GD, Rosenberg M, Neiman HL, Patterson R. The spectrum of radiologic findings in ABPA. Radiology 1978;127:301-307.
142. Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2002;110:685-692.
143. Rosenberg M, Patterson R, Mintzer R, Cooper BJ, Roberts M, Harris KE. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med 1977;86:405-414.
144. Patterson R, Greenberger PA, Lee TM, Liotta JL, O'Neill EA, Roberts M et al. Prolonged evaluation of patients with corticosteroid-dependent asthma stage of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1987;80:663-668.
145. Salez F, Brichet A, Desurmont S, Grosbois JM, Wallaert B, Tonnel AB. Effects of itraconazole therapy in allergic bronchopulmonary aspergillosis. Chest 1999;116:1665-1668.
146. Wark PA, Gibson PG. Allergic bronchopulmonary aspergillosis: new concepts of pathogenesis and treatment. Respirology 2001;6:1-7.
147. Stevens DA, Schwartz HJ, Lee JY, Moskovitz BL, Jerome DC, Catanzaro A et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000;342:756-762.
148. Wark PA, Hensley MJ, Saltos N, Boyle MJ, Toneguzzi RC, Epid GD et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol 2003;111:952-957.
149. Wark P. Pathogenesis of allergic bronchopulmonary aspergillosis and an evidence-based review of azoles in treatment. Respir Med 2004;98:915-923.
150. Liebow AA. The J. Burns Amberson lecture. Pulmonary angiitis and granulomatosis. Am Rev Respir Dis 1973;108:1-18.
151. Katzenstein AL, Liebow AA, Friedmann PJ. Bronchocentric granulomatosis, mucoid impaction and hypersensitivity reaction to fungi. Am Rev Respir Dis 1975;111:497-537.
152. Robinson RG, Wehnut WD, Tsou E, Koss MN, Hochhelzer L. Bronchocentric granulomatosis. Roentgenographic manifestations. Am Rev Respir Dis 1982;125:751-756.
153. Ward S, Heyneman LE, Flint JD, Leung AN, Kazerooni EA, Muller NL. Bronchocentric granulomatosis: computed tomographic findings in five patients. Clin Radiol 2000;55:296-300.
154. Yermakov VM, Hitti IF, Sutton AL. Necrotizing vasculitis associated with diphenylhydantoin: two fatal cases. Hum Pathol 1983;13:182-184.
155. Rich AR. The role of hypersensitivity in periarteritis nodosa as indicated by seven cases developing during serum sickness and sulfonamide therapy. Bull Johns Hopkins Hosp 1942;71:123-141.
156. Hertzman PA, Blevins WL, Mayer J, Greenfield B, Ting M, Gleich GJ. Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. N Engl J Med 1990;322:869-873.
157. Alonso-Ruiz A, Calabozo M, Perez-Ruiz F, Mancebo L. Toxic oil syndrome. A long-term follow-up of a cohort of 332 patients. Medicine (Baltimore) 1993;72:285-295.
158. Crestani B, Valeyre D, Roden S, Wallaert B, Dalphin JC, Cordier JF. Bronchiolitis obliterans organizing pneumonia syndrome primed by radiation therapy to the breast. The Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GER-M'O'P). Am J Respir Crit Care Med 1998;158:1929-1935.
159. Cottin V, Frognier R, Monnot H, Levy A, DeVuyst P, Cordier JF. Chronic eosinophilic pneumonia after radiation therapy for breast cancer. Eur Respir J 2004;23:9-13.
160. Van Vyve T, Chanez P, Lacoste JY, Bousquet J, Michel FB, Godard P. Comparison between bronchial and alveolar samples of bronchoalveolar lavage fluid in asthma. Chest 1992;102:356-361.
161. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002;360:1715-1721.
162. Gibson PG, Dolovich J, Denburg J, Ramsdale EH, Hargreave FE. Chronic cough: eosinophilic bronchitis without asthma. Lancet 1989;1:1346-1348.
163. Gibson PG, Fujimura M, Niimi A. Eosinophilic bronchitis: clinical manifestations and implications for treatment. Thorax 2002;57:178-182.
164. Niimi A, Amitani R, Suzuki K, Tanaka E, Murayama T, Kuze F. Eosinophilic inflammation in cough variant asthma. Eur Respir J 1998;11:1064-1069.
165. Brightling CE, Symon FA, Birring SS, Bradding P, Wardlaw AJ, Pavord ID. Comparison of airway immunopathology of eosinophilic bronchitis and asthma. Thorax 2003;58:528-532.
166. Thomson NC, Chaudhuri R. Why is eosinophilic bronchitis not asthma? Am J Respir Crit Care Med 2004;170:4-5.
167. Brightling CE, Woltmann G, Wardlaw AJ, Pavord ID. Development of irreversible airflow obstruction in a patient with eosinophilic bronchitis without asthma. Eur Respir J 1999;14:1228-1230.
168. Park SW, Lee YM, Jang AS, Lee JH, Hwangbo Y, Kim do J et al. Development of chronic airway obstruction in patients with eosinophilic bronchitis: a prospective follow-up study. Chest 2004;125:1998-2004.
169. Dicpinigaitis PV. Cough. 4: Cough in asthma and eosinophilic bronchitis. Thorax 2004;59:71-72.
170. Takayanagi N, Kanazawa M, Kawabata Y, Colby TV. Chronic bronchiolitis with associated eosinophilic lung disease (eosinophilic bronchiolitis). Respiration 2001;68:319-322.
171. Turner-Warwick M, Haslam PL. The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. Am Rev Respir Dis 1987:135:26-34.
172. Haslam PL, Turton CWG, Lukoszek A, Salsbury AJ, Dewar A, Collins JV et al. Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy. Thorax 1980;35:328-339.
173. Rudd RM, Haslam PL, Turner-Warwick M. Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Am Rev Respir Dis 1981;124:1-8.
174. Yousem SA. Eosinophilic pneumonia-like areas in idiopathic usual interstitial pneumonia. Mod Pathol 2000;13:1280-1284.
175. Cordier JF, Cottin V. Cryptogenic organising pneumonia (bronchiolitis obliterans organising pneumonia). In: Gibson GJ, Geddes DM, Costabel U, Sterk PJ, Corrin B, editors. Respiratory medicine, 3rd edn. London: Saunders, 2003:1581-1590.
176. Lieberman PH, Jones CR, Steinman RM, Erlandson RA, Smith J, Gee T et al. Langerhans cell (eosinophilic) granulomatosis. A clinicopathologic study encompassing 50 years. Am J Surg Pathol 1996;20:519-552.
177. Travis WD, Borok Z, Roum JH, Zhang J, Feuerstein I, Ferrans VJ et al. Pulmonary Langerhans cell granulomatosis (histiocytosis X). A clinicopathologic study of 48 cases. Am J Surg Pathol 1993;17:971-986.
178. Renston JP, Goldman ES, Hsu RM, Tomashefski JF Jr. Peripheral blood eosinophilia in association with sarcoidosis. Mayo Clin Proc 2000;75:586-590.
179. Yousem SA. Graft eosinophilia in lung transplantation. Hum Pathol 1992;23:1172-1177.
180. Bewig B, Stewart S, Bottcher H, Bastian A, Tiroke A, Hirt S et al. Eosinophilic alveolitis in BAL after lung transplantation. Transpl Int 1999;12:266-272.
181. Horie S, Okubo Y, Suzuki J, Isobe M. An emaciated man with eosinophilic pneumonia. Lancet 1996;348:166.